Pharmacokinetic properties and oral bioavailabilities of difloxacin in pig and chicken
- 1 January 1998
- journal article
- Published by Taylor & Francis in Xenobiotica
- Vol. 28 (9) , 887-893
- https://doi.org/10.1080/004982598239128
Abstract
1. Pharmacokinetic properties of difloxacin have been studied in pig and chicken after intravenous and oral administration. 2. The serum concentrations of difloxacin in pig and chicken after intravenous administration were best described by a two-compartment open model, giving distribution half-lives of 0.50 and 0.66 h and elimination half-lives of 7.92 and 4.10 h for pig and chicken respectively. The steady-state distribution volumes were 1.70 and 3.06 l/kg for pig and chicken respectively. 3. After oral administration of 5 mg/kg to pig and chicken, the serum concentrations reached maximal levels of 3.61 and 0.96 microg/ml respectively at 1.25 and 1.40 h. The elimination half-lives were 11.8 and 7.35 h for pig and chicken respectively. 4. The bioavailabilities of difloxacin were calculated as 93.7 (pig) and 86.9% (chicken).Keywords
This publication has 8 references indexed in Scilit:
- Pharmacokinetics of enrofloxacin and its metabolite ciprofloxacin after intravenous and oral administration of enrofloxacin in dogsJournal of Veterinary Pharmacology and Therapeutics, 1993
- Pharmacokinetic evaluation of enrofloxacin administered orally to healthy dogsAmerican Journal of Veterinary Research, 1992
- Pharmacokinetic study of danofloxacin in cattle and swineAmerican Journal of Veterinary Research, 1992
- Pharmacokinetic properties of enrofloxacin in rabbitsAmerican Journal of Veterinary Research, 1991
- Susceptibilities of genital mycoplasmas to the newer quinolones as determined by the agar dilution methodAntimicrobial Agents and Chemotherapy, 1989
- High-performance liquid chromatographic procedures for the determination of difloxacin and its metabolites in biological matricesJournal of Chromatography B: Biomedical Sciences and Applications, 1987
- Difloxacin metabolism and pharmacokinetics in humans after single oral dosesAntimicrobial Agents and Chemotherapy, 1986
- In vitro activities of the quinolone antimicrobial agents A-56619 and A-56620Antimicrobial Agents and Chemotherapy, 1985